BioCentury
ARTICLE | Company News

Mylan sales and marketing update

April 21, 2014 7:00 AM UTC

Mylan's Mylan Pharmaceuticals Inc. subsidiary launched in the U.S. a generic version of transdermal contraceptive patch Ortho Evra norelgestromin/ethinyl estradiol from Johnson & Johnson (NYSE:JNJ, ...